195 related articles for article (PubMed ID: 6308652)
21. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
22. v-abl activates embryonic globin gene expression in mouse erythroleukemia cells.
Lopez AR; Barker J; Deisseroth AB
Proc Natl Acad Sci U S A; 1986 Apr; 83(7):2042-6. PubMed ID: 3008148
[TBL] [Abstract][Full Text] [Related]
23. Oncogene mobility in a human leukemia line HL-60.
Wolman SR; Lanfrancone L; Dalla-Favera R; Ripley S; Henderson AS
Cancer Genet Cytogenet; 1985 Jun; 17(2):133-41. PubMed ID: 3857965
[TBL] [Abstract][Full Text] [Related]
24. The breakpoint of the Philadelphia chromosome 22 in chronic myeloid leukaemia is distal to the immunoglobulin lambda light chain constant region genes.
Rabbitts TH; Forster A; Matthews JG
Mol Biol Med; 1983 Jul; 1(1):11-9. PubMed ID: 6436636
[TBL] [Abstract][Full Text] [Related]
25. Secondary activation of c-abl may be related to translocation to the nucleolar organizer region in an in vitro cultured rat leukemia cell line (K3D).
Takahashi R; Mihara K; Maeda S; Yamaguchi T; Chen HL; Aoyama N; Murao S; Hatanaka M; Sugiyama T
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1079-83. PubMed ID: 3456563
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
27. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
[TBL] [Abstract][Full Text] [Related]
28. Elevation of c-abl-mRNA in human leukemic B lymphoblasts.
de Kretser T; Adams F; Devereux L; Garson M; Michael P; Savin K
Leuk Res; 1986; 10(12):1391-9. PubMed ID: 3491935
[TBL] [Abstract][Full Text] [Related]
29. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
30. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.
Shtivelman E; Lifshitz B; Gale RP; Canaani E
Nature; 1985 Jun 13-19; 315(6020):550-4. PubMed ID: 2989692
[TBL] [Abstract][Full Text] [Related]
31. Philadelphia chromosome as the sole abnormality and p210 bcr-abl chimeric protein expression in an Epstein-Barr virus-transformed B cell line from a patient with chronic myeloid leukemia.
Knuutila S; Lindlöf M; Kovanen PE; Ramqvist T; Ruutu T; Andersson LC
Acta Haematol; 1993; 90(4):190-4. PubMed ID: 8140859
[TBL] [Abstract][Full Text] [Related]
32. The human c-abl oncogene in the Philadelphia translocation.
Groffen J; Stephenson JR; Heisterkamp N; Bartram C; de Klein A; Grosveld G
J Cell Physiol Suppl; 1984; 3():179-91. PubMed ID: 6589229
[No Abstract] [Full Text] [Related]
33. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
34. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
[TBL] [Abstract][Full Text] [Related]
35. Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line.
Nowell P; Finan J; Dalla-Favera R; Gallo RC; ar-Rushdi A; Romanczuk H; Selden JR; Emanuel BS; Rovera G; Croce CM
Nature; 1983 Dec 1-7; 306(5942):494-7. PubMed ID: 6580529
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the abl oncogene in human chronic myelogenous leukemia.
Witte ON
Princess Takamatsu Symp; 1986; 17():143-9. PubMed ID: 3332006
[TBL] [Abstract][Full Text] [Related]
37. Transposition of the oncogene c-ets-1 in a t(11;19)(q23;p13) cell line transient during clonal evolution of blast crisis chronic myeloid leukemia.
Morris CM; Whitham SE; Fitzgerald PH
Leukemia; 1988 Feb; 2(2):74-8. PubMed ID: 3422701
[TBL] [Abstract][Full Text] [Related]
38. A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia.
Dayton AI; Selden JR; Laws G; Dorney DJ; Finan J; Tripputi P; Emanuel BS; Rovera G; Nowell PC; Croce CM
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4495-9. PubMed ID: 6589608
[TBL] [Abstract][Full Text] [Related]
39. Rearrangement of bcr and c-abl sequences in Ph-positive acute leukemias and Ph-negative CML--an update.
Bartram CR
Haematol Blood Transfus; 1987; 31():160-2. PubMed ID: 3481751
[No Abstract] [Full Text] [Related]
40. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
